Dosage form of N-acetyl cysteine
US6623754B2 · kind B2 · utility
37Cited by
13References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2001 |
| Grant date | Sep 23, 2003 |
| Priority date | — |
| Expiry date | May 21, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A directly-compressed, controlled release tablet contains N-acetyl cysteine as the active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.